Mai Capital Management Northwest Biotherapeutics Inc Transaction History
Mai Capital Management
- $10.1 Billion
- Q3 2024
A detailed history of Mai Capital Management transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Mai Capital Management holds 20,000 shares of NWBO stock, worth $5,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$5,600
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NWBO
# of Institutions
13Shares Held
674KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC462KShares$129,4200.02% of portfolio
-
Opus Capital Group, LLC60.2KShares$16,8420.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY35KShares$9,8000.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$6,6360.0% of portfolio
-
Lee Danner & Bass Inc20KShares$5,6000.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $290M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...